Introduction
Vaginal candidosis is a widespread gynaecological problem among women of child bearing age. Since the introduction of effective antifungal agents, various regimens of local treatment with pessaries, tablets, creams, tampons, and even foaming pessaries have been tried. These have varied from 14 day courses of nystatin' and 15 day courses of miconazole impregnated tampons2 to a three day course of clotrimazole vaginal tablets. The cure rates in these trials have ranged from 97.4%2 to 89-4%3 one month after treatment. Several attempts have been made to assess the relationship between anorectal (colonic candida) and vaginal candidosis.' 4 5 Combined oral and vaginal treatment, however, has proved no more effective in the long term than local treatment.
Over the past few years it has become increasingly evident that the success of any treatment depends on patient compliance. Single dose treatment of vaginal candidosis: clotrimazole and isoconazole compared for colonies of Candida spp at once and after 48 hours' incubation at 37°C. Colonies of Candida spp were incubated in plasma at room temperature and examined microscopically for germ tubes. If germ tubes were present, the colonies were incubated at room temperature in corn meal agar and examined for chlamydospores daily for up to five days.
Either a single 500 mg clotrimazole tablet, or two 300 mg isoconazole tablets, allocated according to a randomisation code, were inserted into the vagina by the investigator using an applicator. Clotrimazole cream was given to the patients for the treatment of their sexual partners, and they were asked to abstain from sexual intercourse until after the first follow up visit.
Follow up examinations were carried out seven and 35 days after treatment. On both these occasions two specimens were taken for culture and the relevant physical signs and symptoms recorded. Patients were asked at day 7 to give their opinion on the acceptability of the preparation administered. Those found to be culture positive for Candida spp at day 7 were regarded as treatment failures. Adverse events or side effects were noted.
Results
Each treatment group contained 50 women, and the two groups are compared in table I. All patients were positive for Candida spp at the first visit. The results of mycological examination at the follow up visits are shown in table II. There was a very low default rate.
One patient in the clotrimazole group and three in the isoconazole group failed to attend on day 35. Two patients treated with clotrimazole and one treated with isoconazole were excluded at day 35 as they had started additional antibiotic treatment. Two patients being treated with isoconazole developed severe side effects consisting of oedema and redness of the vulva and vagina. One of these was withdrawn from the trial and treated by painting the affected area with 1% aqueous solution of gentian violet. One 
